Lafora rare disease could be aggravated by oxidative stress

Neurodegenerative Lafora disease usually becomes apparent through seizures during adolescence and puberty and occurs as a consequence of defects in glycogen metabolism and in the cellular mechanisms that are responsible for its disposal. Researchers at the University of Valencia have led a study in which they propose that Lafora rare disease could be aggravated by oxidative stress. These ideas have been put forward in a review article recently published in the journal Free Radical Biology and Medicine.

Researcher Carlos Romá-Mateo, one of the lead authors of this paper - written by a joint group formed by the University, Ciberer and Incliva, in collaboration with the Institute of Biomedicine of Valencia (IBV-CSIC) and the Príncipe Felipe Research Center (CIPF) - explains that oxidative stress is "an aggravating factor for the molecular processes, in charge of eliminating useless substances, that are damaged in Lafora disease and is emerging as an interesting field of study to fully understand the complex etiology of this disease".

This study is linked to a previous investigation in which these same authors defined that the levels of cellular oxidative stress were high in models of human cells and experimental animals for Lafora disease, and they proposed mitochondrial damage as a possible cause for these high levels of oxidative stress.

Romá-Mateo comments that under normal conditions defective mitochondria are eliminated by cellular mechanisms, which are affected in Lafora disease. Consequently, as noted by this scientist of the University of Valencia, "the relationship between the defects to eliminate aberrant substances and increased oxidative stress that we observed may reflect the consequences of mitochondrial damage accumulated". This argument has been presented in the article published in the special issue of Free Radical Biology and Medicine, dedicated to rare diseases and oxidative stress.

For his part, the director of the joint group, made up of the University, the Ciberer and Incliva and focused on Lafora disease, Professor of Physiology Federico Pallardó stresses that this project "would not have been possible without the collaboration of the team led by Pascual Sanz, international leader in studying Lafora disease, from the the IBV-CSIC, and coordinated by Erwin Knecht, from the CIPF". "The complementary work of several groups generating interdisciplinary synergies is always important in science, but in the field of rare diseases it is especially necessary", says the Professor, who is also the dean of the Faculty of Medicine and Dentistry.

Source: University of Valencia